October 7, 2019

Leadership 101: Get the Basics from Cleveland Clinic’s Director of Physician Leadership (Video)

Brian Bolwell, MD, provides insights


There are plenty of books and courses about how to lead in business. But leadership guidance for hospital settings is hard to come by. And it’s sorely needed, since academic medicine — where multidisciplinary teams are essential — tends to reward and promote those with track records of individual accomplishment, not successful collaboration.


Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

In this 18-minute video recorded at the Case Comprehensive Cancer Center’s 2019 scientific retreat, Cleveland Clinic Director of Physician Leadership Brian Bolwell, MD, provides a concise overview of healthcare leadership essentials. It’s knowledge gained from his long tenure as Chairman of Taussig Cancer Institute and Cleveland Clinic Cancer Center, a position in which Dr. Bolwell supervises more than 250 cancer specialists and oversees the treatment and research efforts of the nation’s No. 6 cancer program as ranked by U.S. News & World Report.

Dr. Bolwell regularly expresses his leadership philosophy in speeches, videos, tweets and his blog, “Straight Talk,” for Oncology Times.


Related Articles

Dr. Jagadeesh at Cleveland Clinic
February 28, 2024
Treating Patient with Systemic T-Cell Lymphoma and Graft-Versus-Host Disease

A case study on the value of access to novel therapies through clinical trials

Doctor measuring patient's waist size
February 26, 2024
Impact of Obesity on GVHD & Transplant Outcomes in Hematologic Malignancies

Findings highlight an association between obesity and an increased incidence of moderate-severe disease

Physician with patient
February 21, 2024
Strategies for Improving Clinical Trial Equity

Cleveland Clinic Cancer Institute takes multi-faceted approach to increasing clinical trial access

How antibody drug conjugates work
February 13, 2024
Real-World Use of Trastuzumab Deruxtecan

Key learnings from DESTINY trials

February 7, 2024
Advances in Bone Marrow Transplant Have Improved Outcomes in Fanconi Anemia

Overall survival in patients treated since 2008 is nearly 20% higher than in earlier patients

February 5, 2024
Haploidentical Bone Marrow Transplant Has Durable Engraftment in Patients With Sickle Cell Disease

Two-year event-free survival comparable to matched sibling donor myeloablative transplant

February 1, 2024
Possibilities of CRISPR Technology (Podcast)

Gene editing technology offers promise for treating multiple myeloma and other hematologic malignancies, as well as solid tumors

January 30, 2024
Gene Therapy Trials Show Positive Results in Sickle Cell Disease and Thalassemia

First-in-human trials of CRISPR-Cas12a gene editing demonstrate safety and meaningful event-free survival